LOTUS BIOSCIENCE VENTURES
Lotus BioScience Ventures finances seed, early, and mid stage companies in the biotherapeutics industry.
LOTUS BIOSCIENCE VENTURES
Status:
Active
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2008-09-23 | Humanigen | Lotus BioScience Ventures investment in Series D - Humanigen | 20 M USD |
2005-10-19 | Nereus Pharmaceuticals | Lotus BioScience Ventures investment in Series D - Nereus Pharmaceuticals | 42.6 M USD |
2005-08-11 | Anadys Pharmaceuticals | Lotus BioScience Ventures investment in Private Equity Round - Anadys Pharmaceuticals | 71.3 M USD |
2005-03-16 | Humanigen | Lotus BioScience Ventures investment in Series B - Humanigen | 20 M USD |
2002-06-24 | Infinity Pharmaceuticals | Lotus BioScience Ventures investment in Series B - Infinity Pharmaceuticals | 70 M USD |
2002-04-25 | Dynavax Technologies | Lotus BioScience Ventures investment in Series D - Dynavax Technologies | 34.8 M USD |
More informations about "Lotus BioScience Ventures"
Lotus BioScience Ventures - Crunchbase
Lotus BioScience Ventures finances seed, early, and mid stage companies in the biotherapeutics industry.See details»
Lotus Bioscience Ventures Investor Profile: Portfolio & Exits
Mar 6, 2006 · Information on investments, active portfolio, exits, fund performance, dry powder, team and co-investors for Lotus Bioscience Ventures. Use the PitchBook Platform to explore …See details»
Lotus BioScience Ventures - Investments, Portfolio & Company Exits
Lotus BioScience Ventures finances seed, early, and mid stage companies in the biotherapeutics industry.See details»
Lotus Biosciences Ventures - Company Profile and News
Lotus Biosciences Ventures operates as a private equity firm. The Company serves customers in Hong Kong.See details»
Lotus Bioscience Ventures - CB Insights
The firm is a venture capital investor focused on biosciences and is based in Hong Kong, China. Use the CB Insights Platform to explore Lotus Bioscience Ventures's full profile.See details»
Lotus Bioscience Ventures - Investor, Hong Kong - SWFI
Lotus Bioscience Ventures: Investor in Hong Kong, Asia. Lotus Bioscience Ventures is a Investor located in Hong Kong, Asia. Request Profile Update; Download DataSee details»
Lotus BioScience Investment Holdings - PitchBook
Apr 25, 2002 · Information on investments, active portfolio, exits, fund performance, dry powder, and co-investors for Lotus BioScience Investment Holdings. Use the PitchBook Platform to …See details»
Lotus BioScience Ventures - Updates, News, Events, Signals
Lotus BioScience Ventures finances seed, early, and mid stage companies in the biotherapeutics industry.See details»
Lotus BioScience Ventures - BioCentury Company Profiles - BCIQ
Lotus BioScience Ventures - BioCentury Company Profiles for the biopharma industrySee details»
Lotus Bioscience - 6 Investments - Tracxn
Lotus Bioscience has made 6 investments across sectors such as Antibody Based Immunotherapy, Infectious Diseases, Rare Diseases and others. Humanigen, Humanigen and …See details»
KaloBios Raises $20 Million - venturecapitaljournal.com
Sep 23, 2008 · KaloBios Pharmaceuticals Inc., a South San Francisco-based developer of antibody therapeutics, has raised $20 million in the first close of its Series D funding round.See details»
Lotus BioScience Ventures - Unicorn Nest
The leading representative office of defined VC is situated in the Hong Kong. The usual cause for the fund is to invest in rounds with 7-8 partakers. Despite the Lotus BioScience Ventures, …See details»
Canadian Venture Capital-Funded Biotech Companies to Watch in …
Feb 1, 2023 · Lumira Ventures and Amplitude Ventures are the most active Canadian headquartered biotech VCs, primarily participating in Seed and Series A rounds. Multiple …See details»
Eluminex Biosciences Announces First Patient Dosed in the Phase …
Jul 15, 2024 · LOTUS is a multicenter, single intravitreal (IVT) injection dose escalation study that will evaluate three dose levels of EB-105 in patients with center-involved diabetic macular …See details»
Aulos Bioscience doses first patient in avelumab lung cancer trial
1 day ago · US-based immuno-oncology company Aulos Bioscience has announced the first patients have been dosed as part of a trial investigating avelumab, marketed as Bavencio by …See details»
Lotus Lake Ventures Portfolio Companies - Crunchbase
Feb 11, 2012 · Lotus Lake Ventures is an investment firm committed to investing in science and technology innovation enterprises. This list of organizations invested in by Lotus Lake …See details»
Hanoi Lotus Spa Vinhome Smart City - Dưỡng Sinh Đông Y & Trị …
Hanoi Lotus Spa Vinhome Smart City - Dưỡng Sinh Đông Y & Trị Liệu, Me Tri, Ha Noi, Vietnam. 4,124 likes · 1 talking about this. -Chuyên các Dịch vụ CSSK Dưỡng Sinh Vùng đầu & Cơ thể. …See details»
NextX - Phần mềm CRM quản lý và chăm sóc khách hàng toàn diện
Chúng tôi mang đến cho khách hàng giải pháp chuyển đổi số quản lý kinh doanh tổng thể All-in-One với hơn 50 phân hệ trên duy nhất một nền tảng gồm các phân hệ NextX CRM, NextX …See details»
Google Maps
Find local businesses, view maps and get driving directions in Google Maps.See details»
Hanoi Lotus Spa Vinhome Smart City - Facebook
Hanoi Lotus Spa Vinhome Smart City - Dưỡng Sinh Đông Y & Trị Liệu, Me Tri, Ha Noi, Vietnam. 4,145 likes · 1 talking about this. -Chuyên các Dịch vụ CSSK Dưỡng Sinh Vùng đầu & Cơ thể. …See details»